Pyxis Oncology reports Q2 2026 results, advances MICVO milestones
Pyxis Oncology (PYXS) reports second-quarter 2026 financial results and says it is advancing MICVO toward key 2026 clinical milestones, according to the company release.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.